v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | EUCTR2020-001209-22-GB |
Full text link
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001209-22/GB |
First author
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
|
Contact
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
principle@phc.ox.ac.uk |
Registration date
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
2020-03-25 |
Recruitment status
Last imported at : Jan. 4, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Recruiting |
Study design
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
RCT |
Allocation
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Randomized |
Design
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Parallel |
Masking
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Open label |
Center
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
multi-center |
Study aim
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Treatment |
Inclusion criteria
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Participant is willing and able to give informed consent for participation in the study. Participant is willing to comply with all trial procedures Onset of symptoms of possible COVID-19 in the community (continuous cough and/or high temperature) within 7 days of inclusion Patients aged ≥50-64 years with any of the following listed comorbidities: - known weakened immune system due to a serious illness or medication (e.g. chemotherapy) - known heart disease - known asthma or lung disease - known diabetes not treated with insulin - known mild hepatic impairment - known stroke or neurological problem OR Patients aged ≥65 with or without comorbidity |
Exclusion criteria
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Pregnancy Breastfeeding Known severe hepatic impairment Known severe renal impairment Known acute porphyrias Type 1 diabetes or insulin dependent Type 2 Diabetes mellitus Known G6PD deficiency Known myasthenia gravis Known severe Psoriasis Known severe neurological disorders (especially those with a history of epilepsy may lower seizure threshold) Previous adverse reaction to, or currently taking, hydroxychloroquine Known retinal disease Judgement of the recruiting clinician deems ineligibile |
Number of arms
Last imported at : Nov. 13, 2020, 12:30 a.m. Source : EU Clinical Trials Register |
2 |
Funding
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
University of Oxford / Clinical Trials and Research Governance |
Inclusion age min
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
50 |
Inclusion age max
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
None |
Countries
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
United Kingdom |
Type of patients
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Mild disease at enrollment |
Severity scale
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
1: Mild disease at enrollment |
Total sample size
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
3000 |
primary outcome
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Hospital admission or mortality related to suspected COVID-19. |
Notes
Last imported at : Nov. 13, 2020, 12:30 a.m. Source : EU Clinical Trials Register |
Declared number of arm (2.0) differs from found arms (4.0) |
Phase
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Phase 3 |
Arms
Last imported at : Nov. 13, 2020, 12:30 a.m. Source : EU Clinical Trials Register |
[{"arm_notes": "", "treatment_id": 607, "treatment_name": "Hydroxychloroquine", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |